Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


31.08.2026

2 Am Heart J
1 Am J Emerg Med
3 Am J Med
1 Arterioscler Thromb Vasc Biol
1 Circ Cardiovasc Interv
1 Circ Heart Fail
8 Circulation
3 Clin Cardiol
1 Dtsch Med Wochenschr
6 Eur Heart J
3 Heart
1 Hypertension
9 Int J Cardiol
6 J Am Coll Cardiol
5 JAMA
1 Mol Cell Biochem
1 PLoS One
3 Prog Cardiovasc Dis
1 Thromb Haemost


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. PHILLIPS LM, Jones PG, Shaw LJ, Mark DB, et al
    Health Status Relationship to Ischemia and Coronary Artery Disease Severity in the ISCHEMIA Trial.
    Am Heart J. 2026 Aug 25:107586. doi: 10.1016/j.ahj.2026.107586.
    PubMed         Abstract available

  2. HON JJ, Aikawa T, Biering-Sorensen T, Crouch E, et al
    Comparative effectiveness of influenza vaccination dosing strategies for cardiovascular protection: a systematic review and network meta-analysis of randomised controlled trials.
    Am Heart J. 2026 Aug 24:107591. doi: 10.1016/j.ahj.2026.107591.
    PubMed         Abstract available


    Am J Emerg Med

  3. MORRISSEY B
    Acute urinary retention presenting as inferior pseudo-STEMI: A case report.
    Am J Emerg Med. 2026;108:143-146.
    PubMed         Abstract available


    Am J Med

  4. FAUCHIER L, Bouteau J, Genet T
    Crossing curves, uncertain effects: Spironolactone in heart failure with preserved ejection fraction after myocardial infarction.
    Am J Med. 2026;139:e292-e293.
    PubMed        

  5. PARK MK, Causland FRM, Ravi KS
    Inflammation-Associated Cardiovascular Risk Differs According to SSRI Use in Patients with Chronic Kidney Disease.
    Am J Med. 2026 Aug 25:S0002-9343(26)00610-8. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available

  6. CIRILLO P, Berteotti M, Galli M, Gargiulo G, et al
    Pretreatment with P2Y12 inhibitors in Acute and Chronic Coronary Syndromes: for whom, when and how.
    Am J Med. 2026 Aug 24:S0002-9343(26)00613-3. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  7. GE H, Xu D, He T, Zhang Z, et al
    miR487a-3p and miR6855-3p Facilitate Macrophage Proinflammatory Polarization and Lipid Accumulation in Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2026;46:e325069.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  8. TAKAHASHI T, Wei J, Ahn A, Hagena H, et al
    Stability of Compounded Intracoronary Acetylcholine and Implications for Beyond-Use Dating.
    Circ Cardiovasc Interv. 2026 Aug 25:e017021.
    PubMed        


    Circ Heart Fail

  9. CARNICELLI AP, Lin P, Di Salvo TG, Wald JW, et al
    Stepping Down Without Stepping Back: Financial Implications of Impella 5.5 Management on Cardiovascular Stepdown Units.
    Circ Heart Fail. 2026 Aug 27:e014055. doi: 10.1161/CIRCHEARTFAILURE.125.014055.
    PubMed        


    Circulation

  10. SRIVASTAVA M
    The Clinical Images in Cardiovascular Medicine Section.
    Circulation. 2026;154:785.
    PubMed        

  11. HASIFIC S, Ovrehus KA, Mejldal A, Hosbond S, et al
    Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082363.
    PubMed         Abstract available

  12. DAVIS JW, Manson JE
    Cholecalciferol and Menaquinone Supplementation: Does Prevention of Coronary Artery Calcium Progression Mean Heart Benefit?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082639.
    PubMed        

  13. LAUER MS
    Coronary Artery Calcium (CAC): From Marker to Treatment Target?
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082642.
    PubMed        

  14. BOHULA EA, Morrow DA
    Vasoactive Agent Selection Strategies in the Management of Cardiogenic Shock.
    Circulation. 2026;154:775-784.
    PubMed         Abstract available

  15. LU B, Liu W, Ge Z, Zou J, et al
    Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction.
    Circulation. 2026 Aug 25. doi: 10.1161/CIRCULATIONAHA.125.079049.
    PubMed         Abstract available

  16. MA L, Hu Y, Liu G, Rexrode KM, et al
    Association of Adherence to Various Dietary Patterns With Mortality Among Survivors of Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2026 Aug 25:10.1161/CIRCULATIONAHA.126.079972.
    PubMed         Abstract available

  17. MILLS NL (ESC CHAIRPERSON) (UN, Kristin Newby L (ACC/AHA Co-Chairperson) (United States of America), Zaman S (WHF Co-Chairperson) (Australia), Almahmeed
    Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Def
    Circulation. 2026 Aug 27. doi: 10.1161/CIR.0000000000001477.
    PubMed        


    Clin Cardiol

  18. EL-SEHRAWY AAMA, Sayed U, Nasirova Z, Tursunov Q, et al
    Mechanistic Insights Into the Association Between Gut Microbiota Diversity and Atherosclerosis, Acute Coronary Syndrome, and Peripheral Arterial Disease Progression.
    Clin Cardiol. 2026;49:e70455.
    PubMed         Abstract available

  19. JIANG S, Zheng Y, Pan K, Ma L, et al
    Artificial Intelligence in Coronary Computed Tomography Angiography: A Bibliometric Analysis of Trends and Themes.
    Clin Cardiol. 2026;49:e70447.
    PubMed         Abstract available

  20. OUYANG X, Chen X, He F, Li Q, et al
    Tobacco-Attributable Burden of Early-Onset Ischemic Heart Disease From 1990 to 2023: A Global Analysis Using GBD 2023 and Age-Period-Cohort Modeling.
    Clin Cardiol. 2026;49:e70451.
    PubMed         Abstract available


    Dtsch Med Wochenschr

  21. SCHNEIDER T, Laufs U
    [Lipid-lowering therapy in transition: implications of the ESC/EAS focused update].
    Dtsch Med Wochenschr. 2026;151:961-967.
    PubMed         Abstract available


    Eur Heart J

  22. SEPEHRI SHAMLOO A, Chiba T, Tijssen JGP, Althof T, et al
    Mortality reduction with implanted defibrillator for primary prevention of sudden death after Myocardial Infarction: temporal trends in the PROFID study.
    Eur Heart J. 2026 Aug 28:ehag706. doi: 10.1093.
    PubMed         Abstract available

  23. NAIR A, van der Kaaij NP, Kluin J, Rogers J, et al
    Total artificial hearts: an evolution on the horizon.
    Eur Heart J. 2026;47:4396-4409.
    PubMed         Abstract available

  24. HEUSCH G, Kleinbongard P, Gourine AV
    The vagus nerve in myocardial infarction.
    Eur Heart J. 2026 Aug 26:ehag674. doi: 10.1093.
    PubMed         Abstract available

  25. BAI B, Cao L, Lin K, Luo C, et al
    Aerobic exercise attenuates peri-infarct fibrosis and improves fitness early after acute myocardial infarction: a randomized trial.
    Eur Heart J. 2026 Aug 26:ehag651. doi: 10.1093.
    PubMed        

  26. MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
    Fifth Universal Definition of Myocardial Infarction (2026).
    Eur Heart J. 2026 Aug 28:ehag101. doi: 10.1093.
    PubMed        

  27. DE FERRARI GM, Giugliano RP, Leiter LA, Nicolau JC, et al
    Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
    Eur Heart J. 2026 Aug 28:ehag739. doi: 10.1093.
    PubMed        


    Heart

  28. SCHIOPU A, Svedlund S, Narasimhan G, Juin Loong B, et al
    Circulating soluble LOX-1 and patient prognosis after an acute coronary syndrome.
    Heart. 2026;112:1014-1021.
    PubMed         Abstract available

  29. JIN IT, Lee SJ, Lee JY, Kim SM, et al
    Optical coherence tomography-guided percutaneous coronary intervention in multivessel coronary disease with complex lesions.
    Heart. 2026 Aug 26:heartjnl-2026-328499. doi: 10.1136/heartjnl-2026-328499.
    PubMed         Abstract available

  30. QUETSCH M, Kette F, Tavella R, Beltrame J, et al
    Allergic vasospastic angina: a systematic review.
    Heart. 2026;112:997-1003.
    PubMed         Abstract available


    Hypertension

  31. CHI C, Li J, Yang H, Teliewubai J, et al
    Cf-PWV Versus ba-PWV in Predicting Cardiovascular Events: Insights From a Community-Based Cohort.
    Hypertension. 2026 Aug 24. doi: 10.1161/HYPERTENSIONAHA.125.25929.
    PubMed         Abstract available


    Int J Cardiol

  32. KATASH HA, Zornitzki L, Freund O, Loewenstein I, et al
    Atrial fibrillation and coronary microvascular dysfunction-A clinical signal.
    Int J Cardiol. 2026 Jul 29:134706. doi: 10.1016/j.ijcard.2026.134706.
    PubMed         Abstract available

  33. ARBATLI S, Yucel-Lindberg T, Thunstrom E, Peker Y, et al
    Effects of CPAP on endothelial activation and fibrinolytic balance in coronary artery disease with obstructive sleep apnea: The RICCADSA randomized controlled trial.
    Int J Cardiol. 2026;462:134701.
    PubMed         Abstract available

  34. HELAL A, Farooqui A, Cader FA, Giannini F, et al
    Clinical outcome of coronary sinus reducer in refractory angina: A prospective real-world observational study.
    Int J Cardiol. 2026;462:134709.
    PubMed         Abstract available

  35. DE JONG EAM, Kapteijn DMC, Daniels MA, Nijkamp T, et al
    Feasibility of endothelial cell isolation from routine coronary function testing in ANOCA patients.
    Int J Cardiol. 2026;462:134711.
    PubMed         Abstract available

  36. PARK J, Poletti E, Thotakura S, Kearney KE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients ineligible for surgical revascularization.
    Int J Cardiol. 2026;462:134716.
    PubMed         Abstract available

  37. EMARA A, Awashra A, Mansour A, Azim AAA, et al
    Clinical and procedural outcomes of IVUS-guided versus angiography-guided PCI in unprotected left main coronary disease: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2026 Aug 26:134755. doi: 10.1016/j.ijcard.2026.134755.
    PubMed         Abstract available

  38. GABALDON-BADIOLA A, Esquivel JR, Rumiz E, Oteo JF, et al
    Endothelial dysfunction and long-term outcomes in patients with myocardial infarction and non-obstructive coronary arteries.
    Int J Cardiol. 2026 Aug 27:134750. doi: 10.1016/j.ijcard.2026.134750.
    PubMed         Abstract available

  39. ZHAO W, Ruan G, Wang H, Li M, et al
    An interpretable machine learning approach to predict left ventricular aneurysm formation following primary PCI in STEMI: A retrospective study with independent external validation.
    Int J Cardiol. 2026;462:134702.
    PubMed         Abstract available

  40. ZHONG B, King B, Mares RG, Arbanasi EM, et al
    Activation of the complement lectin pathway is associated with long-term cardiac dysfunction and incident heart failure in acute coronary syndrome patients.
    Int J Cardiol. 2026 Jul 24:134699. doi: 10.1016/j.ijcard.2026.134699.
    PubMed         Abstract available


    J Am Coll Cardiol

  41. BENOWITZ NL
    Cannabis and Cardiac Ectopy: Implications for Cardiovascular Disease Prevention.
    J Am Coll Cardiol. 2026 Aug 12:S0735-1097(26)07313.
    PubMed        

  42. BERLACHER K, Weissman G
    20 Signals, 1 Cycle: What We Did-and Didn't-Learn About Cardiovascular Disease Fellowship Recruitment.
    J Am Coll Cardiol. 2026 Aug 13:S0735-1097(26)07309.
    PubMed        

  43. BLUMER V, Sinha SS, Carnicelli AP, Isseh IN, et al
    Cardiogenic Shock Survivorship: A Multidisciplinary Approach Across the Continuum of Care.
    J Am Coll Cardiol. 2026;88:831-848.
    PubMed         Abstract available

  44. FUSTER V, Vazirani R
    Interpreting Contemporary PCI for Diabetes and Multivessel Coronary Disease After FREEDOM.
    J Am Coll Cardiol. 2026;88:828-830.
    PubMed        

  45. MILLS NL, Newby LK, Zaman S, Almahmeed WA, et al
    Fifth Universal Definition of Myocardial Infarction (2026).
    J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07248.
    PubMed        

  46. NICOLAU JC, Murphy SA, Giugliano RP, Leiter LA, et al
    Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.
    J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07440.
    PubMed         Abstract available


    JAMA

  47. HUANG X, Petito LC, Allen NB, Blankstein R, et al
    Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations.
    JAMA. 2026 Aug 26. doi: 10.1001/jama.2026.13233.
    PubMed         Abstract available


  48. Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: Research Summary.
    JAMA. 2026 Aug 28:e2617332. doi: 10.1001/jama.2026.17332.
    PubMed        

  49. SELVANAYAGAM JB, Cleland JGF, Hillis GS, Pasupathy S, et al
    Cardiovascular Magnetic Resonance to Guide Defibrillator Implantation for LVEF of 36% to 50%: The CMR GUIDE Randomized Clinical Trial.
    JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17078.
    PubMed         Abstract available

  50. ABBASI J
    Cardiovascular Care Should Incorporate Cognition and Frailty, Heart Group Says in New Statement.
    JAMA. 2026 Aug 28. doi: 10.1001/jama.2026.17524.
    PubMed        

  51. RAZO C, DeCleene NK, Johnson CO, Stark BA, et al
    Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.
    JAMA. 2026 Jul 29:e268628. doi: 10.1001/jama.2026.8628.
    PubMed         Abstract available


    Mol Cell Biochem

  52. WU Y, Wang X, Zhao J, Yang H, et al
    Small extracellular vesicles induced by Angiotensin-(1-7) enhance cardioprotection following myocardial ischemia-reperfusion injury.
    Mol Cell Biochem. 2026 Aug 28. doi: 10.1007/s11010-026-05710.
    PubMed         Abstract available


    PLoS One

  53. WANG G, Zhang Z, Yang G, Wang J, et al
    Identification of candidate macrophage-ferroptosis crosstalk genes associated with immune infiltration in myocardial infarction: A bioinformatics analysis.
    PLoS One. 2026;21:e0356358.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  54. MALDONADO LE, Ostfeld RJ, Rodriguez CJ
    Beyond diet quality for cardiovascular prevention socioeconomic context and unequal cardiovascular risk.
    Prog Cardiovasc Dis. 2026 Aug 23:S0033-0620(26)00082.
    PubMed        

  55. LIU R, Arena R, Vasile VC, Arruda-Olson AM, et al
    Artificial intelligence for risk prediction in atherosclerotic cardiovascular disease: A narrative review of advances, validation challenges, and clinical translation (2020-2026).
    Prog Cardiovasc Dis. 2026 Aug 26:S0033-0620(26)00097.
    PubMed         Abstract available

  56. BEVERLOO CYY, Stroes ESG, Nurmohamed NS
    Defining inflammation in cardiovascular risk: A complex challenge.
    Prog Cardiovasc Dis. 2026 Aug 26:S0033-0620(26)00096.
    PubMed        


    Thromb Haemost

  57. GALUSKO V, Panoulas V, Gorog DA, Vandenbriele C, et al
    Stroke in Mechanical Circulatory Supported Cardiogenic Shock.
    Thromb Haemost. 2026;126:883-896.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum